Table 2.

Survival analysis according to time-varying MRD positivity (time points)

	TTP risk for MRD positivity by RQ-PCR in BM at different time points
	TTP
RQ-PCR POS in BM (subjects)	HR	95% CI	P value
R-CTX (#167)	1.50	(0.94-2.37)	.086
R-HD-ARAC (#141)	1.50	(0.86-2.62)	.2
Post-ASCT (#138)	1.81	(1.02-3.20)	.043
M6 (#99)	3.82	(1.92-7.62)	<.001
M12 (#90)	5.60	(2.68-11.7)	<.001

M6, 6 months from transplant; M12, 12 months from transplant.